Friday, November 15, 2024

TraceLink Secures Merit Award for Healthcare Innovation with AI-Powered Product Availability Intelligence Solution

Related stories

ServiceNow Enhances Autonomous AI with GenAI & Governance

New Now Assist capabilities drive greater visibility and controls...

Kovai.co Acquires Floik to Boost Document360

London-based, Kovai.co - a premier enterprise software and B2B...

Multiverse Computing Launches ML Classification in Qiskit

Multiverse Computing, a leading quantum AI software company, announced...

Diagrid’s, Open Source Dapr Adds LLM Interface for App Integration

Diagrid, provider of enterprise tools and services for building...
spot_imgspot_img

TraceLink Inc., the leading digital network platform company enabling end-to-end product orchestration by connecting more than 291,000 healthcare and life sciences entities through its B2N Integrate-Once™ network, is proud to announce that its innovative Product Availability Intelligence (PAI) solution has been recognized with a Bronze award by the prestigious Merit Awards for Healthcare Innovation. Product Availability Intelligence leverages the collective intelligence of the TraceLink network to flag drug shortages up to 90 days in advance so they can be successfully mitigated.

The Merit Awards for Healthcare celebrate advancements in healthcare, honoring organizations that have demonstrated exceptional use of technology to meet a wide range of healthcare needs—in this case, addressing the critical challenge of escalating drug shortages in the United States.

TraceLink customers are excited to partner on innovations that improve patient care.

“Recognizing the critical challenge of drug shortages in healthcare, Boston Medical Center is committed to excellence in patient care. This commitment has led us to collaborate with TraceLink,” said M. Ross Casey, PharmD, MBA, CSP, Director of Supply Chain & 340B Optimization at Boston Medical Center. “Together, we’re implementing forward-thinking strategies to anticipate and protect our patients from the impact of drug shortages.”

Also Read: ConcertAI’s TeraRecon Enhances its Eureka Clinical AI Platform with AI-Based Prostate Cancer Diagnostic Solutions from Lucida Medical

In 2023, the ASHP Drug Shortages Survey Report highlighted a concerning peak, with 309 active drug shortages—the highest in nearly a decade. TraceLink Product Availability Intelligence successfully predicted 70% of these shortages. Customers of PAI have harnessed our platform to avert shortages for hundreds of thousands of patients, exemplifying our commitment to safeguarding patient health and ensuring medication availability.

The Merit Awards for Healthcare acknowledge the relentless efforts and achievements of global industries and the markets they serve, spotlighting companies that have significantly contributed to the market’s growth. TraceLink’s recognition at the annual event underscores the company’s role as a pioneer in the digital transformation of healthcare.

“This award is a testament to the hard work and dedication of our team who are committed to driving innovation in healthcare,” said Shabbir Dahod, President and CEO of TraceLink. “As we celebrate this achievement, we remain focused on advancing our technology to meet the complex challenges of today’s global healthcare supply chain.”

SOURCE: PRNewswire

Subscribe

- Never miss a story with notifications


    Latest stories

    spot_img